Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1996-11-15
|
pubmed:abstractText |
The intestinal transport mechanism of 5-fluorouracil (5-FU) was investigated in the intestinal everted sacs and brush border membrane vesicles (BBMVs) of rats. In the everted sacs, the initial uptake of 5-FU was apparently Na(+)-dependent, in terms of the inhibition of the uptake by replacing the Na+ in the medium with K+, and also concentration-dependent in the presence of Na+, with a maximum transport rate of 0.74 +/- 0.24 nmol/min/cm and a Michaelis constant of 0.025 +/- 0.018 mM. Passive transport was also significant, with a membrane permeability clearance of 5.9 +/- 0.6 microliters/min/cm. The uptake of 5-FU was inhibited by pyrimidines (uracil and thymine) and 2, 4-dinitrophenol (DNP), a metabolic inhibitor, but not by purines (adenine and guanine), pyrimidine nucleosides (thymidine and uridine), L-alanine or D-glucose. These results suggest the involvement of carrier-mediated transport specific to pyrimidines in intestinal 5-FU transport, and this appeared to satisfy the criteria of Na(+)-dependent secondary active transport. However, in BBMVs, 5-FU uptake was independent of Na+, minimally dependent on concentration and not inhibited by thymine, though slightly inhibited by uracil. 5-FU uptake was also independent of pH, outward HCO3- gradient and valinomycin-induced K+ diffusion potential. Thus, the carrier-mediated transport of 5-FU, or presumably pyrimidines, may require some other factors, which are yet to be identified, in addition to Na+. Alternatively, Na+ may not be prerequisite, and something else may be required in the absence of K+, as suggested from an additional result in everted sacs that the replacement of NaCl in the medium with mannitol failed to inhibit 5-FU uptake.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0918-6158
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
94-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8820919-Animals,
pubmed-meshheading:8820919-Antimetabolites, Antineoplastic,
pubmed-meshheading:8820919-Biological Transport, Active,
pubmed-meshheading:8820919-Culture Media,
pubmed-meshheading:8820919-Fluorouracil,
pubmed-meshheading:8820919-Intestinal Absorption,
pubmed-meshheading:8820919-Intestines,
pubmed-meshheading:8820919-Male,
pubmed-meshheading:8820919-Microvilli,
pubmed-meshheading:8820919-Rats,
pubmed-meshheading:8820919-Rats, Wistar,
pubmed-meshheading:8820919-Sodium
|
pubmed:year |
1996
|
pubmed:articleTitle |
Intestinal brush border transport mechanism of 5-fluorouracil in rats.
|
pubmed:affiliation |
Faculty of Pharmaceutical Sciences, Nagoya City University, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|